A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PtGA / patient global assessment

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PtGA  (>> Co-occurring Abbreviation)
Long Form:   patient global assessment
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Split Face Comparative Study of Safety and Efficacy of Microneedling with Tranexamic Acid versus Microneedling with Vitamin C in the Treatment of Melasma. PGA
2020 Automated Text Message-Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial. DAS28, RA, SMS
2020 Development and preliminary validation of the Behcet's syndrome Overall Damage Index (BODI). BDCAF, BODI, BS, PGA, VDI
2020 Utility of the Brief Illness Perception Questionnaire to Monitor Patient Beliefs in Systemic Vasculitis. AAV, BIPQ, GCA, IPQ-R, MFI, PhGA, RP, SF-36, TAK
2020 Validation of a Patient Global Assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES). SA-VES
2020 Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa. CI, DLQI, HiSQOL, HRQoL, HS, NRS
2018 Defining new clinically derived criteria for high disease activity in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study. cJADAS10, HDA, PGA
2018 Latent profile analysis approach to the relationship between patient and physician global assessments of rheumatoid arthritis activity. LPA, RA
2018 Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional Study. HCRU, HRQoL, PsA
10  2018 The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients. CDAI, PhGA, RA, TNF
11  2017 Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials. ADA, FACIT, HAQ-DI, MCS, MTX, PCS, PROs, RA, SF-36, TCZ
12  2017 Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors. csDMARDs, HAQ-DI, MCID, PROs, RA, RAID, SF-36, TNF-IR, WPS-RA, WPS-RA
13  2016 Changes in foot function, disease activity, and disability after forefoot resection arthroplasty in patients with rheumatoid arthritis. ---
14  2016 Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term? HRQoL, PROs, RA
15  2016 Study of the Effect of an Oral Formulation of Fig and Olive on Rheumatoid Arthritis (RA) Remission Indicators: A Randomized Clinical Trial. DMARDs, RA
16  2015 Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. PhGA, PsA
17  2014 Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's). BVAS/WG, GPA, PhGA, VAS, WGET
18  2014 Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort. ERA, OR, PGA, TJC
19  2013 A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study. TBCR
20  2013 Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort. CI, HAQ-DI, PhGA, RA, VAS
21  2013 One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian population. DLQI, PGA
22  2013 Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity. CCalpha, CFA, CID, ICC, PASI, PGA
23  2013 Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers. ACR, EULAR, RA
24  2013 Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity. DLQI, PSI
25  2012 Disease severity evaluation among dermatological out-patients: a comparison between the assessments of patients and physicians. PhGA
26  2012 Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA. MDHAQ, WPAI
27  2012 Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria. ACR/EULAR, ERA